Cargando…

A genetically engineered, stem-cell-derived cellular vaccine

Despite rapid clinical translation of COVID-19 vaccines in response to the global pandemic, an opportunity remains for vaccine technology innovation to address current limitations and meet challenges of inevitable future pandemics. We describe a universal vaccine cell (UVC) genetically engineered to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Amanda, Sidaway, Adam, Chandrashekar, Abishek, Latta, Elizabeth, Chakraborty, Krishnendu, Yu, Jingyou, McMahan, Katherine, Giffin, Victoria, Manickam, Cordelia, Kroll, Kyle, Mosher, Matthew, Reeves, R. Keith, Gam, Rihab, Arthofer, Elisa, Choudhry, Modassir, Henley, Tom, Barouch, Dan H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727836/ https://www.ncbi.nlm.nih.gov/pubmed/36480934 http://dx.doi.org/10.1016/j.xcrm.2022.100843

Ejemplares similares

Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics
por: Sivapalan, Rohan, et al.
Publicado: (2021)

Vaccines Elicit Highly Cross-Reactive Cellular Immunity to the SARS-CoV-2 Omicron Variant
por: Liu, Jinyan, et al.
Publicado: (2022)

Vaccines elicit highly conserved cellular immunity to SARS-CoV-2 Omicron
por: Liu, Jinyan, et al.
Publicado: (2022)

CMV Primes Functional Alternative Signaling in Adaptive Δg NK Cells but Is Subverted by Lentivirus Infection in Rhesus Macaques
por: Shah, Spandan V., et al.
Publicado: (2018)

Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
por: Barouch, Dan H., et al.
Publicado: (2021)

Durable Humoral and Cellular Immune Responses Following Ad26.COV2.S Vaccination for COVID-19
por: Barouch, Dan H., et al.
Publicado: (2021)

A bivalent SARS-CoV-2 monoclonal antibody combination does not impact the immunogenicity of a vector-based COVID-19 vaccine in macaques
por: Nkolola, Joseph P., et al.
Publicado: (2022)

Modeling HCV disease in animals: virology, immunology and pathogenesis of HCV and GBV-B infections
por: Manickam, Cordelia, et al.
Publicado: (2014)

Silent damage? Occult HCV replication and histological disease may occur following apparent HCV clearance
por: Manickam, Cordelia, et al.
Publicado: (2019)

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly
por: Viney, Lydia, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of GBP510/AS03 vaccine against SARS-CoV-2 delta challenge in rhesus macaques
por: Jacob-Dolan, Catherine, et al.
Publicado: (2023)

Coronavirus-Specific Antibody Cross Reactivity in Rhesus Macaques following SARS-CoV-2 Vaccination and Infection
por: Jacob-Dolan, Catherine, et al.
Publicado: (2021)

Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020
por: Manickam, Cordelia, et al.
Publicado: (2020)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant
por: Collier, Ai-ris Y., et al.
Publicado: (2022)

Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids
por: Mietzsch, Mario, et al.
Publicado: (2021)

Innate Lymphoid Cells in HIV/SIV Infections
por: Shah, Spandan V., et al.
Publicado: (2017)

NK cell education: Physiological and pathological influences
por: Rascle, Philippe, et al.
Publicado: (2023)

Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism
por: Sugawara, Sho, et al.
Publicado: (2023)

Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus Macaques
por: Yu, Jingyou, et al.
Publicado: (2022)

Monkeying Around: Using Non-human Primate Models to Study NK Cell Biology in HIV Infections
por: Manickam, Cordelia, et al.
Publicado: (2019)

Characterization of Rhesus Macaque Liver-Resident CD49a(+) NK Cells During Retrovirus Infections
por: Ram, Daniel R., et al.
Publicado: (2020)

Metabolic Dysregulation in Hepacivirus Infection of Common Marmosets (Callithrix jacchus)
por: Manickam, Cordelia, et al.
Publicado: (2017)

Cytokine-Mediated Tissue Injury in Non-human Primate Models of Viral Infections
por: Manickam, Cordelia, et al.
Publicado: (2018)

Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine
por: Gebre, Makda S., et al.
Publicado: (2021)

Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
por: Chandrashekar, Abishek, et al.
Publicado: (2021)

Probiotic supplementation reduces inflammatory profiles but does not prevent oral immune perturbations during SIV infection
por: Jones, Rhianna, et al.
Publicado: (2021)

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques
por: He, Xuan, et al.
Publicado: (2022)

Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
por: Collier, Ai-ris Y., et al.
Publicado: (2021)

Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques
por: Ventura, John D., et al.
Publicado: (2022)

Antigen-specific NK cell memory in rhesus macaques
por: Reeves, R. Keith, et al.
Publicado: (2015)

Comparable Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
por: Yu, Jingyou, et al.
Publicado: (2022)

Approaches and Challenges in SARS-CoV-2 Vaccine Development
por: Dagotto, Gabriel, et al.
Publicado: (2020)

Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
por: Tan, C. Sabrina, et al.
Publicado: (2022)

Experimental and Computational Approaches to Direct Cell Reprogramming: Recent Advancement and Future Challenges
por: Gam, Rihab, et al.
Publicado: (2019)

CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques
por: Liu, Jinyan, et al.
Publicado: (2022)

A modular protein subunit vaccine candidate produced in yeast confers protection against SARS-CoV-2 in non-human primates
por: Dalvie, Neil C., et al.
Publicado: (2021)

Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
por: Mahrokhian, Shant H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g4lff6vtuooio0iv5oou45gvik